These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22718404)

  • 1. [Preferences for oral anticoagulant treatment in the medium and long term prevention of stroke in non valvular atrial fibrillation].
    González-Rojas N; Giménez E; Fernández MÁ; Heineger AI; Martínez JL; Villar J; Lizán L
    Rev Neurol; 2012 Jul; 55(1):11-9. PubMed ID: 22718404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
    Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
    Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study.
    Alonso-Coello P; Montori VM; Solà I; Schünemann HJ; Devereaux P; Charles C; Roura M; Díaz MG; Souto JC; Alonso R; Oliver S; Ruiz R; Coll-Vinent B; Diez AI; Gich I; Guyatt G
    BMC Health Serv Res; 2008 Oct; 8():221. PubMed ID: 18954427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New anticoagulants for the prevention of stroke in atrial fibrillation.
    Höchtl T; Huber K
    Fundam Clin Pharmacol; 2012 Feb; 26(1):47-53. PubMed ID: 21883447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
    Martí-Fàbregas J; Mateo J
    Cerebrovasc Dis; 2009; 27 Suppl 1():111-9. PubMed ID: 19342840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Limitations of anticoagulant therapy].
    Martí-Fàbregas J; Delgado-Mederos R; Mateo J
    Neurologia; 2012 Mar; 27 Suppl 1():27-32. PubMed ID: 22682207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cardioembolic stroke in atrial fibrillation and new anticoagulation criteria: a therapeutic dare].
    Perez-Ortega I; Moniche-Alvarez F; Jimenez-Hernandez MD; Gonzalez-Marcos JR
    Rev Neurol; 2012 Jul; 55(2):74-80. PubMed ID: 22760766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke prevention in atrial fibrillation: current status and near-future directions.
    De Caterina R; Hylek EM
    Am J Med; 2011 Sep; 124(9):793-9. PubMed ID: 21745652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meeting the unmet needs in anticoagulant therapy.
    Weitz JI
    Eur J Haematol Suppl; 2010 Jul; (72):1-28. PubMed ID: 20553560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preferences for oral anticoagulant treatment in the medium and long term prevention of stroke in non valvular atrial fibrillation].
    Abdel-Kader Martín L; Vega-Coca MD; Beltrán-Calvo C; Molina-López T
    Rev Neurol; 2012 Nov; 55(9):575-6. PubMed ID: 23111997
    [No Abstract]   [Full Text] [Related]  

  • 11. Vitamin K antagonists in patients with nonvalvular atrial fibrillation: appropriateness and quality of treatment in an Italian cohort.
    Pereira de Sousa L; Burba I; Ruperto C; Lattuada L; Barbone F; Di Chiara A
    J Cardiovasc Med (Hagerstown); 2013 Jul; 14(7):534-40. PubMed ID: 23328227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stroke prevention in atrial fibrillation.
    Freedman B; Potpara TS; Lip GY
    Lancet; 2016 Aug; 388(10046):806-17. PubMed ID: 27560276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New oral anticoagulants in development.
    Weitz JI
    Thromb Haemost; 2010 Jan; 103(1):62-70. PubMed ID: 20062934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New anticoagulants for atrial fibrillation.
    De Caterina R; Kristensen SD; Renda G
    J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):446-53. PubMed ID: 19365276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EHRA practical guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
    Heidbuchel H; Verhamme P; Alings M; Antz M; Hacke W; Oldgren J; Sinnaeve P; Camm AJ; Kirchhof P
    Eur Heart J; 2013 Jul; 34(27):2094-106. PubMed ID: 23625209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiplatelet and anticoagulant therapy for stroke prevention in patients with non-valvular atrial fibrillation: evidence based strategies and new developments].
    Gersh BJ; Freedman JE; Granger CB
    Rev Esp Cardiol; 2011 Apr; 64(4):260-8. PubMed ID: 21411211
    [No Abstract]   [Full Text] [Related]  

  • 17. Dabigatran and factor Xa inhibitors for stroke prevention in patients with nonvalvular atrial fibrillation.
    Uchiyama S; Ibayashi S; Matsumoto M; Nagao T; Nagata K; Nakagawara J; Tanahashi N; Tanaka K; Toyoda K; Yasaka M
    J Stroke Cerebrovasc Dis; 2012 Apr; 21(3):165-73. PubMed ID: 22440950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New oral anticoagulants: their role in stroke prevention in high-risk patients with atrial fibrillation.
    Ferns SJ; Naccarelli GV
    Med Clin North Am; 2015 Jul; 99(4):759-80. PubMed ID: 26042881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for new oral anticoagulants in clinical practice.
    Hylek EM
    J Cardiovasc Med (Hagerstown); 2009 Aug; 10(8):605-9. PubMed ID: 19571764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation.
    Wisler JW; Becker RC
    Crit Pathw Cardiol; 2012 Jun; 11(2):55-61. PubMed ID: 22595815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.